Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 Sep - Ellenbarrie wins ₹481 crore BHEL ASU contract for Odisha coal-to-ammonium nitrate project, commissioning expected in FY29.
Source: Bse
Chemicals stocks · Micro cap · NSE
Ellenbarrie Industrial Gases Limited is an Indian industrial gas manufacturer with over 50 years of legacy. It supplies a wide range of industrial gases (Oxygen, Nitrogen, Argon, Acetylene, Hydrogen, CO2, Helium, Nitrous Oxide, Specialty Gases) and offers project engineering services. The company operates through Onsite, Bulk, and Packaged models, serving diverse industries like steel, chemicals, healthcare, and manufacturing across India.
SMA20 +2.5% / mo · MACD − · sector -5.7pp vs Nifty 500 (3M)
Latest FPI flow is positive, but a second consecutive positive fortnight is still required. View sector evidence
Adjusted completed-session prices, rebased to 100
Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is consistent.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +17.9% · PAT +84.2% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +18% YoY · PAT +84% YoY · margin expansion · +14% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹99 Cr | +17.9% | +13.8% |
| EBITDA | ₹38 Cr | +22.6% | +40.7% |
| Operating margin | 38.0% | +100 bps | +700 bps |
| PAT | ₹35 Cr | +84.2% | +52.2% |
| PAT margin | 35.4% | +1273 bps | +891 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 21/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term uptrend intact. RSI 40. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 49 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Ellenbarrie reported strong FY26 performance with Total Income up 12% YoY to INR 3,916 mn and PAT up 25% YoY to INR 1,044 mn. Q4FY26 saw Total Income grow 9% YoY to INR 1,020 mn, but PAT declined 12% QoQ due to one-off items. Core Gases revenue grew 14.2% YoY in FY26 and 8.6% QoQ in Q4FY26, with segment margins expanding.
The core gases business demonstrates robust growth and margin expansion, driven by operational leverage and new capacities. Management's focus on high-return organic projects and strategic acquisitions, coupled with a strong balance sheet, supports future growth. Near-term macro pressures and Argon price volatility are noted, but the overall outlook for FY27 appears positive with new plants commissioning.
Latest issuer-disclosed distribution across 6 reported categories.
Merchant plant - Uluberia 2 ramp up progressing well, focus on increasing capacity utilization into FY27.
New on-site plant in East India expected operational next month, revenues to start in H2FY27.
New merchant plants in North India (FY27) and West/Central India (FY28) to be operational.
Consolidate market via acquisition of smaller players and expand product portfolio.
320 TPD, expected operational June 2026, revenues to start H2FY27.
220 TPD, status H2 2027.
Capacity TBD, status FY28e onwards.
220 TPD, commissioned in FY26, ramp-up progressing.
Expected to grow at ~7.5% CAGR from 2024 to 2028, backed by end-use industries.
Rising demand from chemicals, steel, healthcare, and pharma sectors.
Argon prices recovered in H2FY26, momentum expected to continue into FY27.
FY26 margins impacted by softness in Argon prices in H2FY26.
Industrial activity faces some near-term pressure from the broader macro environment.
Project engineering (non-core) revenue declined 62% as division refocused on internal execution.
Changes in international oil prices and input costs can affect ability to implement business strategies.
Risk and uncertainties regarding intense competition and pricing environment in the market.
Changes in regulatory environments and new or changed priorities of trade.
Q4FY26 EBITDA margin weighed down by one-off items (employee leave, impairment, settlement).
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The presentation provides both YoY and QoQ comparisons for Q4FY26, which is crucial for understanding both annual growth trends and sequential momentum, especially for core gases revenue and margins, and the impact of one-off items in the quarter.
INR 3,916 mn
INR 1,044 mn
14.2% YoY
40.0%
Continue to focus on increasing capacity utilization further into FY27 for Uluberia 2.
New on-site plant in East India expected operational next month, revenues to start in H2FY27.
Reinvest in high-return organic projects (ROCE >15%) and fund new growth initiatives.
Preserve a net-cash balance sheet for capex flexibility.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Uluberia 2 Capacity Utilization | Ramp-up progressing well. | Further increase in utilization rates into FY27. |
| East India On-site Plant Revenue | Expected to start in H2FY27. | Timely commissioning and revenue contribution. |
| Adjusted EBITDA Margin | 35% for Q4FY26 (ex-one-offs). | Sustained margin levels and recovery from Argon price softness. |
| New Plant Capex Execution | FY27e: INR 2500 mn, FY28e: INR 2000 mn. | Adherence to capex guidance and commissioning timelines. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 86th percentile of the scored universe and 77th percentile within Chemicals. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Chemicals: 77th pctile, median 73 · Micro: 74th pctile, median 73
21 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse